
Validea's guru fundamental report indicates that UNITEDHEALTH GROUP INC (UNH) receives a 69% rating based on their Growth Investor model, which is based on the investment strategy of Martin Zweig. The analysis highlights strengths in UNH's P/E ratio, revenue growth, sales growth rate, and current quarter earnings, while noting weaknesses in earnings persistence, long-term EPS growth, and earnings growth compared to the previous year. Zweig's historical success includes a 15.9% average annual return in his stock recommendation newsletter.
UnitedHealth Group Inc. (UNH) has received a 69% rating according to Validea's Growth Investor model, which is based on Martin Zweig's strategy focusing on growth stocks with persistent, accelerating earnings and sales growth, reasonable valuations, and low debt. This rating is below the 80% threshold that typically indicates strategy interest. The assessment reveals a bifurcated fundamental profile: UNH meets criteria for its P/E ratio, revenue growth relative to EPS growth, sales growth rate, current quarter earnings performance (including positive growth rate and outperformance compared to the prior three quarters and historical growth rates), and positive insider transaction signals. However, the company fails on several critical growth and consistency metrics, including quarterly earnings compared to one year ago, the earnings growth rate over the past several quarters, overall earnings persistence, and long-term EPS growth. This suggests that while current operational momentum and valuation may be favorable in some aspects, the consistency and acceleration of earnings growth, key tenets of the Zweig strategy, are not yet fully demonstrated, aligning with the 'mixed' overall sentiment and slightly negative (-0.1) sentiment specific to UNH.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment